Header Logo

Connection

DANIEL DESALVO to Male

Back to Details
This is a "connection" page, showing publications DANIEL DESALVO has written about Male.
DANIEL DESALVO
Connection Strength
0.415
Male
  1. Real-World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes. Pediatr Diabetes. 2025; 2025:5053872.
    View in: PubMed
    Score: 0.037
  2. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod? 5 Automated Insulin Delivery System. Diabetes Technol Ther. 2024 06; 26(6):383-393.
    View in: PubMed
    Score: 0.035
  3. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.034
  4. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res. 2018; 2018:5162162.
    View in: PubMed
    Score: 0.024
  5. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes. 2018 11; 19(7):1271-1275.
    View in: PubMed
    Score: 0.024
  6. Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care. 2015 Oct; 38(10):e166-7.
    View in: PubMed
    Score: 0.019
  7. Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control. J Diabetes Sci Technol. 2014 Sep; 8(5):969-73.
    View in: PubMed
    Score: 0.018
  8. Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther. 2014 01; 16(1):1-7.
    View in: PubMed
    Score: 0.017
  9. In children with premature adrenarche, bone age advancement by 2 or more years is common and generally benign. J Pediatr Endocrinol Metab. 2013; 26(3-4):215-21.
    View in: PubMed
    Score: 0.016
  10. Severe and Recurrent Diabetic Ketoacidosis in Children and Youth with Type 1 Diabetes: Risk and Protective Factors. Diabetes Technol Ther. 2025 Oct; 27(10):801-811.
    View in: PubMed
    Score: 0.009
  11. Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025 May 01; 48(5):768-775.
    View in: PubMed
    Score: 0.009
  12. SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2025 Jun; 224:112218.
    View in: PubMed
    Score: 0.009
  13. Psychosocial outcomes with the Omnipod? 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. Diabetes Obes Metab. 2024 12; 26(12):5569-5579.
    View in: PubMed
    Score: 0.009
  14. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.009
  15. Promoting Resilience in Stress Management for Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2024 08 01; 7(8):e2428287.
    View in: PubMed
    Score: 0.009
  16. Real-World Evidence of Omnipod? 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 08; 26(8):514-525.
    View in: PubMed
    Score: 0.009
  17. Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. 2023; 2023:6718115.
    View in: PubMed
    Score: 0.008
  18. Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatr Diabetes. 2023; 2023:6906023.
    View in: PubMed
    Score: 0.008
  19. Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes. JAMA Netw Open. 2021 09 01; 4(9):e2126126.
    View in: PubMed
    Score: 0.007
  20. Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. J Clin Endocrinol Metab. 2021 03 25; 106(4):e1755-e1762.
    View in: PubMed
    Score: 0.007
  21. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 06 16; 323(23):2388-2396.
    View in: PubMed
    Score: 0.007
  22. Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med. 2020 12; 37(12):2109-2115.
    View in: PubMed
    Score: 0.007
  23. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabet Med. 2020 08; 37(8):1308-1315.
    View in: PubMed
    Score: 0.007
  24. Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes. Diabetes Technol Ther. 2020 09; 22(9):697-700.
    View in: PubMed
    Score: 0.007
  25. "I'm essentially his pancreas": Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8?years old with type 1 diabetes. Pediatr Diabetes. 2020 03; 21(2):377-383.
    View in: PubMed
    Score: 0.007
  26. The Transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D Exchange Registry and those included in the German/Austrian DPV registry. Diabet Med. 2020 05; 37(5):848-855.
    View in: PubMed
    Score: 0.006
  27. Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring. Diabet Med. 2019 11; 36(11):1508-1510.
    View in: PubMed
    Score: 0.006
  28. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technol Ther. 2019 09; 21(9):493-498.
    View in: PubMed
    Score: 0.006
  29. Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry. Diabetes Obes Metab. 2019 01; 21(1):170-172.
    View in: PubMed
    Score: 0.006
  30. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers. Diabetes Technol Ther. 2017 06; 19(6):363-369.
    View in: PubMed
    Score: 0.005
  31. Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes. 2018 02; 19(1):114-120.
    View in: PubMed
    Score: 0.005
  32. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017 01 28; 389(10067):369-380.
    View in: PubMed
    Score: 0.005
  33. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. J Diabetes Sci Technol. 2016 11; 10(6):1268-1276.
    View in: PubMed
    Score: 0.005
  34. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. Diabetes Technol Ther. 2016 07; 18(7):429-35.
    View in: PubMed
    Score: 0.005
  35. Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015 Oct; 38(10):e158-9.
    View in: PubMed
    Score: 0.005
  36. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014 Aug; 37(8):2310-6.
    View in: PubMed
    Score: 0.004
  37. Five-year follow-up of carpal tunnel release in patients over age 65. J Hand Surg Am. 2010 Feb; 35(2):207-11.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.